STOCK TITAN

Regency Ctrs Corp Financials

REG
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Regency Ctrs Corp (REG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI REG FY2025

Regency Centers’ earnings gains reflect a stable overhead structure, while recurring cash flow supports a financed asset base.

From FY2023 to FY2025, revenue climbed from $1.32B to $1.55B. With SG&A still near $100M and operating margin still near 72.0%, the recent profit lift appears to come mostly from more revenue moving through a similar overhead base, not from a broad reset in spending.

The balance sheet carries meaningful leverage: FY2025 long-term debt was $4.74B against cash of just $120.7M. Even with that thin cash cushion, return on assets reached 4.1%, which shows the model is designed to earn on a large asset base rather than sit on idle liquidity.

Operating cash flow rose from $719.6M in FY2023 to $827.7M in FY2025, so cash generation improved even though reported earnings did not move in a straight line. Because dividends paid reached $511.6M and investing outflows stayed heavy, asset growth still came with a higher debt load instead of being financed entirely from retained cash.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 44 / 100
Financial Profile 44/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Regency Ctrs Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
100

Regency Ctrs Corp has an operating margin of 72.3%, meaning the company retains $72 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 72.0% the prior year.

Growth
47

Regency Ctrs Corp's revenue grew 6.9% year-over-year to $1.6B, a solid pace of expansion. This earns a growth score of 47/100.

Leverage
88

Regency Ctrs Corp carries a low D/E ratio of 0.69, meaning only $0.69 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 88/100, indicating a strong balance sheet with room for future borrowing.

Returns
26

Regency Ctrs Corp generates a 7.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 26/100. This is up from 5.9% the prior year.

Piotroski F-Score Neutral
5/9

Regency Ctrs Corp passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.57x

For every $1 of reported earnings, Regency Ctrs Corp generates $1.57 in operating cash flow ($827.7M OCF vs $527.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.6B
YoY+6.9%
5Y CAGR+8.9%

Regency Ctrs Corp generated $1.6B in revenue in fiscal year 2025. This represents an increase of 6.9% from the prior year.

EBITDA
$1.5B
YoY+6.0%

Regency Ctrs Corp's EBITDA was $1.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.0% from the prior year.

Net Income
$527.5M
YoY+31.7%
5Y CAGR+63.7%
10Y CAGR+13.2%

Regency Ctrs Corp reported $527.5M in net income in fiscal year 2025. This represents an increase of 31.7% from the prior year.

EPS (Diluted)
$2.82
YoY+33.6%
5Y CAGR+61.1%

Regency Ctrs Corp earned $2.82 per diluted share (EPS) in fiscal year 2025. This represents an increase of 33.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$120.7M
YoY+95.0%
5Y CAGR-20.4%

Regency Ctrs Corp held $120.7M in cash against $4.7B in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
183M
YoY+0.8%
10Y CAGR+6.5%

Regency Ctrs Corp had 183M shares outstanding in fiscal year 2025. This represents an increase of 0.8% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
72.3%
YoY+0.3pp

Regency Ctrs Corp's operating margin was 72.3% in fiscal year 2025, reflecting core business profitability. This is up 0.3 percentage points from the prior year.

Net Margin
34.0%
YoY+6.4pp
5Y CAGR+29.5pp

Regency Ctrs Corp's net profit margin was 34.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 6.4 percentage points from the prior year.

Return on Equity
7.6%
YoY+1.7pp
5Y CAGR+6.9pp
10Y CAGR+0.3pp

Regency Ctrs Corp's ROE was 7.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.7 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

REG Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $412.5M+2.0% $404.2M+4.3% $387.6M+1.8% $380.8M0.0% $380.9M+2.2% $372.5M+3.4% $360.3M+0.8% $357.3M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $25.6M+1.3% $25.3M-6.6% $27.1M+6.2% $25.5M+18.0% $21.6M-17.0% $26.0M+3.8% $25.1M+3.4% $24.2M
Operating Income $296.4M+3.2% $287.1M+1.9% $281.9M+0.3% $280.9M+2.7% $273.5M+3.3% $264.9M+1.4% $261.2M+1.1% $258.4M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income $128.5M-36.5% $202.5M+85.1% $109.4M+3.2% $106.0M-3.3% $109.6M+26.7% $86.5M-14.8% $101.5M-1.2% $102.7M
EPS (Diluted) $0.68 N/A $0.58+3.6% $0.56-3.4% $0.58 N/A $0.540.0% $0.54

REG Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $13.0B+0.3% $13.0B-0.4% $13.1B+2.6% $12.7B+1.4% $12.6B+1.4% $12.4B-0.3% $12.4B+0.3% $12.4B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $145.6M+20.6% $120.7M-41.3% $205.6M+32.8% $154.8M+97.1% $78.5M+26.9% $61.9M-46.1% $114.8M+43.7% $79.9M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $267.6M-2.3% $273.9M+7.2% $255.5M-2.0% $260.8M+4.2% $250.2M-2.1% $255.5M+6.4% $240.1M+1.3% $237.0M
Goodwill $166.7M0.0% $166.7M0.0% $166.7M0.0% $166.7M0.0% $166.7M0.0% $166.7M0.0% $166.7M-0.2% $167.1M
Total Liabilities $5.9B+1.1% $5.8B-3.0% $6.0B+2.1% $5.9B+3.3% $5.7B+3.5% $5.5B+0.2% $5.5B+1.1% $5.4B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $5.0B+5.6% $4.7B-3.6% $4.9B+2.4% $4.8B+3.4% $4.6B+5.3% $4.4B+0.3% $4.4B+0.7% $4.4B
Total Equity $6.9B-0.2% $6.9B+1.6% $6.8B+1.8% $6.7B-0.3% $6.7B-0.4% $6.7B-0.6% $6.8B-0.4% $6.8B
Retained Earnings N/A N/A N/A N/A N/A N/A N/A N/A

REG Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $152.7M-25.1% $203.9M-6.7% $218.7M-10.4% $244.0M+51.6% $161.0M-15.9% $191.4M-15.9% $227.6M+11.9% $203.5M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$94.9M-477.8% -$16.4M+48.7% -$32.0M+83.4% -$192.5M-6.9% -$180.1M-53.2% -$117.6M-23.9% -$94.9M-436.7% $28.2M
Financing Cash Flow -$32.9M+87.9% -$272.5M-100.5% -$135.9M-648.3% $24.8M-30.7% $35.8M+128.2% -$126.8M-29.7% -$97.8M+74.4% -$381.8M
Dividends Paid $275.9M+115.1% $128.3M+0.4% $127.8M0.0% $127.8M+0.1% $127.7M+5.2% $121.4M-0.4% $121.9M-1.4% $123.6M
Share Buybacks N/A N/A N/A N/A N/A $0 $0 N/A

REG Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin 71.9%+0.8pp 71.0%-1.7pp 72.7%-1.0pp 73.8%+2.0pp 71.8%+0.7pp 71.1%-1.4pp 72.5%+0.2pp 72.3%
Net Margin 31.2%-18.9pp 50.1%+21.9pp 28.2%+0.4pp 27.8%-0.9pp 28.8%+5.6pp 23.2%-5.0pp 28.2%-0.6pp 28.7%
Return on Equity 1.9%-1.1pp 2.9%+1.3pp 1.6%+0.0pp 1.6%-0.1pp 1.6%+0.4pp 1.3%-0.2pp 1.5%-0.0pp 1.5%
Return on Assets 1.0%-0.6pp 1.6%+0.7pp 0.8%0.0pp 0.8%-0.0pp 0.9%+0.2pp 0.7%-0.1pp 0.8%0.0pp 0.8%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 0.73+0.0 0.69-0.0 0.720.0 0.72+0.0 0.69+0.0 0.660.0 0.650.0 0.64
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Regency Ctrs Corp (REG) reported $1.6B in total revenue for fiscal year 2025. This represents a 6.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Regency Ctrs Corp (REG) revenue grew by 6.9% year-over-year, from $1.5B to $1.6B in fiscal year 2025.

Yes, Regency Ctrs Corp (REG) reported a net income of $527.5M in fiscal year 2025, with a net profit margin of 34.0%.

Regency Ctrs Corp (REG) reported diluted earnings per share of $2.82 for fiscal year 2025. This represents a 33.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Regency Ctrs Corp (REG) had EBITDA of $1.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Regency Ctrs Corp (REG) had $120.7M in cash and equivalents against $4.7B in long-term debt.

Regency Ctrs Corp (REG) had an operating margin of 72.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Regency Ctrs Corp (REG) had a net profit margin of 34.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Regency Ctrs Corp (REG) has a return on equity of 7.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Regency Ctrs Corp (REG) generated $827.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Regency Ctrs Corp (REG) had $13.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Regency Ctrs Corp (REG) had 183M shares outstanding as of fiscal year 2025.

Regency Ctrs Corp (REG) had a debt-to-equity ratio of 0.69 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Regency Ctrs Corp (REG) had a return on assets of 4.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Regency Ctrs Corp (REG) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Regency Ctrs Corp (REG) has an earnings quality ratio of 1.57x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Regency Ctrs Corp (REG) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top